At The Bardo Foundation, we believe in making a difference in the lives of those affected by serious illnesses.  That's why we are proud to have contributed $5,000 towards MIB FACTOR 2022, a conference that gathers leading osteosarcoma researchers, clinicians, and patients to advance treatments and improve outcomes for those affected by this disease.

Osteosarcoma is a type of bone cancer that affects children and young adults.  It requires a multi-disciplinary approach to treatment and a collaborative effort from the medical community to find better ways to fight the disease.  This is where MIB FACTOR 2022 comes in, bringing together the best minds in the field to share knowledge and explore new possibilities.

Our contribution to MIB FACTOR 2022 demonstrates The Bardo Foundation's commitment to finding a cure for osteosarcoma. By supporting events like this, we aim to bring together the medical community to work towards a common goal and make a real impact in the lives of patients and their families.

At the conference, attendees had the opportunity to hear from leading experts in the field, including doctors, researchers, and patients.  They discussed the latest developments in osteosarcoma research and explored new treatments and therapies to improve patient outcomes.

We are honored to have supported MIB FACTOR 2022 and to have played a small part in advancing the field of osteosarcoma research.  We hope that our contribution will inspire others to support events like this and continue the important work of finding a cure for osteosarcoma.